Mycophenolate Sodium Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 180mg , 360 mg

Reference Brands: Myfortic®(EU&US)

Category: Nephrology

Mycophenolate Sodium is available in Tablet and strengths such as 180mg , 360 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Mycophenolate Sodium is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Mycophenolate Sodium can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Mycophenolate Sodium Tablets are widely used in nephrology to prevent organ rejection in kidney transplant patients. This immunosuppressive agent, known for its delayed-release formulation, reduces gastrointestinal side effects while maintaining therapeutic efficacy. It is commonly marketed under the brand name Myfortic® in both the US and EU. Mycophenolate Sodium works by inhibiting the proliferation of T and B lymphocytes, crucial for immune response control post-transplantation. Ideal for inclusion in Pharma B2B nephrology product portfolios, these tablets offer high-quality, GMP-compliant manufacturing for global partners. Source Mycophenolate Sodium Tablets today to meet demand in renal care and transplant immunosuppression therapies. Mycophenolate Sodium Tablets are widely used in nephrology to prevent organ rejection in kidney transplant patients. This immunosuppressive agent, known for its delayed-release formulation, reduces gastrointestinal side effects while maintaining therapeutic efficacy. It is commonly marketed under the brand name Myfortic® in both the US and EU. Mycophenolate Sodium works by inhibiting the proliferation of T and B lymphocytes, crucial for immune response control post-transplantation. Ideal for inclusion in Pharma B2B nephrology product portfolios, these tablets offer high-quality, GMP-compliant manufacturing for global partners. Source Mycophenolate Sodium Tablets today to meet demand in renal care and transplant immunosuppression therapies.